Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricMRNAModernaBIIBBiogenONCBeOne Medicines AG
Snapshot
Price$149.19$222.68$362.01
Market cap$31.65B$31.91B$33.43B
Valuation
P/E—23.9x71.9x
Forward P/E—26x—
Growth
Revenue growth-30.0%1.2%36.2%
EPS growth—-8.1%—
Profitability
Net margin-143.6%13.8%7.8%
ROE-36.7%7.5%5.2%
Balance sheet & cash
Debt / equity0.07x0.34x0.25x
Free cash flow yield-13.6%6.8%—
Dividend yield———
Verdict
Investment ratingWeak· 17Neutral· 49Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearMRNAtoday $149BIIBtoday $223ONCtoday $362
2027$114.13 – $167.39+12% CAGR$170.35 – $249.85+12% CAGR$369.74 – $542.28+50% CAGR
2028$116.41 – $170.74+7% CAGR$173.76 – $254.84+7% CAGR$503.51 – $738.48+43% CAGR
2029$118.74 – $174.15+5% CAGR$177.23 – $259.94+5% CAGR$685.68 – $1,005.66+41% CAGR
2030$121.12 – $177.64+4% CAGR$180.78 – $265.14+4% CAGR$933.76 – $1,369.51+39% CAGR
2031$123.54 – $181.19+4% CAGR$184.39 – $270.44+4% CAGR$1,271.59 – $1,865.00+39% CAGR
5-yr CAGR-3.7% – 4.0%-3.7% – 4.0%28.6% – 38.8%